Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluation of Methods for the Determination of Chromogranin A in Routine Blood Samples
This study has been completed.
Study NCT01216267   Information provided by University of Western Ontario, Canada

First Received on October 5, 2010.   Last Updated on January 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Carcinoid Tumor
Carcinoma
Carcinoma, Neuroendocrine
More general conditions related to this trial
Adenocarcinoma
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Interventions listed in this trial
Lansoprazole
Additional drug interventions recognized in this trial
Proton Pump Inhibitors
More general drug interventions related to this trial
Anti-Infective Agents
Anti-Ulcer Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Western Ontario, Canada


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services